MTM Laboratories Planning FDA Filings for Cervical Disease Tests

The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.